Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2000

View Archived Issues

Repronex SC offers subcutaneous IVF therapy

Zadaxin receives expanded marketing approval in Argentina

Onset of inherited neurodegenerative disorders attributed to random cell death

Study commences to evaluate long-term benefit of chronic hepatitis C treatment

Discovery of triclosan resistance may affect antibacterial drug use and development

Gene found to regulate protein associated with immune system disorders

Gene for gastroesophageal reflux disease mapped

Bausch & Lomb to acquire Chauvin

FDA approves Quidel's osteoporosis diagnostic device

Novel 1,2,4-triazole shows promising in vitro antifungal activity

Vernalis designs potent inhibitors of lipid peroxidation and cell toxicity

Merck KGaA and Novartis to comarket Starlix for type 2 diabetes

Chiron's Menjugate approved in Ireland

Cancer treatment found to block HIV replication

Licensing opportunity from NIH: copper complexes

Escherichia coli vaccine shows promise in clinical testing

Diamyd Therapeutics reveals genetically modified forms of rhGAD65

Janssen receives patent for central alpha2-adrenoceptor antagonists

New selective alpha1A receptor antagonists useful for treatment of BPH

New compounds from Novartis useful for proliferative diseases

ATP-regulated potassium channel modulators under development at Novo Nordisk

Newly issued patents cover CCR5 receptor modulators under study at Pfizer

Patent recently issued to Abbott covering MMP inhibitors and their use

Prous Science selected official internet and multimedia provider for XXII ESC Congress

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...